CoChat

Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the Hippocampus

Backstrom, Jon R., Miller, Carol A., Tökés, Zoltán A. · 1992 · Journal of Neurochemistry
Cited by 109

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Three neutral proteinases from human hippocam‐pal tissue have been identified and partially characterized using substrate gel electrophoresis. The proteinases showed activity when gelatin was used as the substrate, but had no detectable activity against casein. Based on the results of inhibition studies and the calcium requirements, it was concluded that the activities were due to calcium‐dependent me‐talloproteinases. The apparent molecular weights were 130,000 (MP‐130), 100,000 (MP‐100), and 70,000 (MP‐70). Half‐maximal activities were observed with 20 μM Ca 2+ for MP‐130,40 μM Ca 2+ for MP‐100, and 800 μM Cn 2+ for MP‐70. In the presence of Ca 2+, Zn 2+ reestablished the activities of the three metalloproteinases at a lower concentration than did either Co 2+ or Mn 2+. One millimolar Al 3+ inhibited 67% of the MP‐70 activity, but did not affect the MP‐100 and MP‐130 activities. An analysis of Alzheimer‐affected hip‐pocampal and control samples showed that the specific activity (in units per milligram of sodium dodecyl sulfate‐soluble protein) of MP‐70 varied less than the activities of MP‐100 and MP‐130 between the two groups. Although p‐amino‐phenylmercuric acetate (p‐APMA) increased the activities of MP‐70 by 70% in both groups of specimens, the resulting activities from Alzheimer samples were greater than those from control samples (p < 0.01). A wide range of MP‐100 specific activity was observed in both groups, and its mean activity was higher in Alzheimer‐affected samples (p < 0.05). Treatment with p‐APMA increased the activity of MP‐100 only 25% in both groups of tissue samples. MP‐130 activity was detected predominantly in Alzheimer‐affected hippo‐campal specimens, and treatment with p‐APMA failed to increase its activity in both the control and the Alzheimer‐affected specimens. The results demonstrate an elevated level of metalloproteinase activities, capable of degrading tissue matrix components, in the hippocampus from postmortem Alzheimer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1992.tb09352.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 109

Metadata

Authors
Backstrom, J. R., Miller, C. A., & Tökés, Z. A.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1992-03
Volume
58
Issue
3
Pages
983-992
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2027985377
Cited by
109
References
2
FWCI
2.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the Hippocampus. https://app.cochat.ai/papers/10.1111/j.1471-4159.1992.tb09352.x
The paper
Backstrom, J. R., Miller, C. A., & Tökés, Z. A. (1992). Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the Hippocampus. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1992.tb09352.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.